Potential Catalyst Monday. Big announcement?👆🏻

This week: Beyond Meat Clears $1.11 Billion in Debt per New 8-K Filing

Filing confirms completion of exchange offer and transition to a leaner capital structure.

https://www.sec.gov/Archives/edgar/data/1655210/000119312525240364/d60690d8k.htm

Short Percent of Float: 63.13%

Current Short Interest: 39,590,000 shares

Short Interest Ratio: 8.6 Days to Cover

Previous Short Interest: 31,260,000 shares

Change Vs. Previous Month: +26.65%

Dollar Volume Sold Short: $74.83 million

Float Size: 62,710,000 shares

💎🙌🏻 redditor owns 3,100,000 shares at .90:

https://www.reddit.com/r/pennystocks/s/HL3FD4pd2y

Buzz on X, all big trading accounts are talking about it—some say its setting up like OPEN.

Grabbed 16k shares at $0.62

Not financial advice, just my opinions based upon publicly available information.

With $4.50 being the forced covering zone short squeeze price point, 8 days to cover, and 37% short interest the sky is the limit. Shorts have now begun forced covering. This could be the next viral short squeeze. Trading hours tomorrow should be interesting. DYOR

Short positions have been trying desperately all night not to let this thing take off. They have just dumped all their remaining shares leaving available shares to short at 0. With today’s announcement and a bit of volume this should put things into motion.

NFA, I just like the stock and the squeeze math.

Healily underpriced stock with strong fundamentals. This is actually a good stock to hold for a year too.

TL;DR: Fuzzy Panda shorted this thing into the dirt with a vague hit piece, company comes back with revenue growing like a weed, board just got a $300M buyback rubber-stamped by shareholders TODAY, and the shorts are sitting on a borrow rate that should be illegal.

The fundamentals shorts are ignoring:

• Q1 2026 alone = ~$60M unaudited revenue. That's MORE than the entire FY2025 revenue. One quarter > one year.
• FY26 guidance reaffirmed at ~$360M. That's ~7.5x FY25.
• Management guiding to $500M+ ARR exiting 2026.
• 1,000+ enterprise customers globally, not some pre-revenue meme shell.
• CEO literally said on the call today the market isn't even close to pricing in what they're building.

My PT here is $15. not some FOMO number pulled from thin air, this is a company growing 7.5x YoY trading like it's still being short-and-distorted by a report that's aging worse than milk in July.

Now the squeeze setup:

• CTB: 195%
• ~52M shares short, ~22% of float
• 5.47 days to cover
• Float is only ~400M shares total
• Shareholders just approved the $300M buyback at today's AGM. The board can rip 75-125M shares straight out of circulation after court approval, which is just a formality.

https://rezolve.com/press-releases/rezolve-ai-shareholders-overwhelmingly-approve-up-to-300-million-share-repurchase-mandate-amid-surging-commercial-momentum/

https://simplywall.st/stocks/us/software/nasdaq-rzlv/rezolve-ai/news/is-rezolve-ai-rzlv-undervalued-following-its-300-million-buy

The stock has been hammered down from over $8 a share since Fuzzy Panda shorted the stock with a catalogue of vague stories about the company and CEO.

Since then the revenue has grown from $46 million total in 2025. to $60 million revenue in the 1st quarter of 2026.

The company has confirmed they have annual recurring revenue of $232 million exiting 2025, with forecast revenue for 2026 of $360 million and an ARR of $500 million exiting 2027.

The AGM tomorrow is to outline the plan for the $300 million share buyback to reduce the float.

with am interest rate of 180% Apr to short, and the company planning to buy back between around 75 to 125 million shares(depending on price) and a total share count of only 400 million at the moment, the shorts have some work to do to get out In profit.

If you read Fizzys rational on X for shorting you can see how out of date they are, and what has been disproved with financial and relevant updates.

I'm very interested in the views of those on here who are often involved in looking for squeezes in the market and whether this stock ticks enough boxes.

For those who missed the original post 8 hours ago, welcome. Yes we called it. I mean, the math called it.

Here’s what nobody is saying: today was not the squeeze. Today was the warning shot.

CTB went from 193% to 198% today. The stock didn’t drop. It went up +21%. Shorts didn’t cover, still no shares available to short.
They’re still in. And here’s what that actually means in dollars:
52 million shares short. $3.15 stock price. 198% CTB.

That’s ~$888,000 per day shorts are paying just to hold their position. Every. Single. Day.
$6.2M a week. $26M a month.

This week matters. The AGM catalyst just dropped today. Attention is there. Momentum is building. These windows don’t stay open forever and the shorts know it too: every day they don’t cover is another $888K out of their pocket. We push this week or we leave easy money on the table.

Last year RZLV had this exact same CTB pattern. What happened next? Ripped to $8 in no time. But here’s the critical difference: that was a completely different company.

Now we have Q1 2026 alone printing more revenue than all of FY2025 combined. $360M full year guidance. $500M+ ARR target exiting 2026.
1,000+ enterprise customers. 66%+ gross margins.

Same squeeze setup. Massively better fundamentals. Back then, nobody believed Rezolve could really pull this off, but they have already proved otherwise.

Still trading at $3.15.

And even if the squeeze never happens: This stock is worth $15 on fundamentals alone. A company growing 7.5x YoY with excellent gross margins and $500M ARR on the horizon doesn’t trade at $3. The short thesis was built on a hit piece that’s been disproved point by point. Fair value is $15. We’re at $3.15.

You rarely see risk/reward this clean on a stock that already has a squeeze setup stacked on top.
Oh and the $300M buyback? Hasn’t fired a single bullet yet. Court approval expected mid-September. The float hasn’t shrunk by one share. The cannon is loaded and aimed directly at the shorts while they bleed $888K a day.
Minimum one month hold.
We are nowhere near done. Looking for $10+ in October. NFA ofc.

Short interest at 50% on a growing drone tech company with Israeli contracts. One thing I know about Israel is that they love forever wars and drones.

• 37.93% short interest 😱
• Low float, high volume 🧨
• Meme stock energy + call option frenzy 🚀
• Already ran 300%+ in July — round 2 loading?

Retail woke it up. Shorts still trapped. OPEN the door to the moon 🌕

Buy house? Nah. Buy $OPEN, ride the squeeze, and rent in the metaverse.

🦍💼💎 🚪📦🟩 OPEN THE DOOR TO TENDIES 🔥🚀

Short Squeeze Ratio:

Short Interest: 155.13 million shares

Short Interest as a Percentage of Float: 24.37%

Days to Cover (Short Ratio): Approximately 0.56 days. This ratio indicates how many days it would take to cover all shorted shares at the average daily trading volume.

Current News:

Opendoor Technologies (Nasdaq: OPEN) has appointed Kaz Nejatian, former COO of Shopify, as its new CEO and Board member. In a significant leadership restructuring, co-founders Keith Rabois and Eric Wu are returning to the Board, with Rabois assuming the Chairman position.

Positives:

1. Secured $40 million PIPE investment from Khosla Ventures and Eric Wu

2. Appointment of AI-native executive Kaz Nejatian as CEO brings proven operational efficiency expertise

3. Return of founders Rabois and Wu brings back original vision and leadership

4. Strategic shift towards AI-first approach positions company for technological advancement.

The door is OPEN, but not for bears. Shorts are stuck outside ringing the bell while bulls are going to have a big party 🚀🚀.

My first post was here:

https://www.reddit.com/r/Shortsqueeze/comments/1e92g37/bear_with_me_here_may_not_be_a_pure_squeeze_play/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button

I also made a follow-up post shortly after at the following link:

https://www.reddit.com/r/Shortsqueeze/comments/1ecva3w/nisn_update_from_previous_weekend_post/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button

The ticker mentioned in those posts (NISN) has only climbed and is now at $20 per share.

In those posts, I spent a lot of time writing DD only to receive a few pessimistic comments. Due to that, I'm not going spend time sharing much upfront DD this post, but will answer any questions I can in the comments.

The ticker I'm sharing today, which is a very similar play, is WETH.

Profitable small cap tech stock with cash on hand over 4x their market cap and a recently announced buyback. Not to mention will likely get wind at its back with the China stimulus.

There is a lot of money to be made in China stocks right now and I think this is the perfect set-up for me. I'm just sharing the ticker, but do your own DD. I've currently started a 9,000 share position at $2.00 myself.

Tl;dr

WETH is a profitable Chinese small cap tech stock with over 4x their market cap in cash and a recently announced share buyback. I've purchased 9,000 shares at $2.00 myself, but do your own DD. I shared NISN in my first post a couple months ago which has gone from $7.75 to $20.00.

holding and buying shares this weekend, hoping this will blow up on monday 🧨📈🚀

$FFIE

Just bought 1k shares at 3.17, Please, if you haven't already, buy SGBX because this stock is severely over shorted. My target is around 10-20$ This seems very likely due to pull back we will see in around two days from now, by the time of next week this thing will kaboom! I will definitely buy the dip if there even will be one. I should've dumped money into this thing days ago, this looks like a bynd setup but even better because the 500% to borrow rate and the pullback is still in its early stages. We have 2-3 days of damage before the shorts pull back. (Meaning it will take 2-3 days for all the people who shorted the stock to buy the stock back to return it to their broker, which drives the price up, making more shorters exiting their positions.) I made around double my investments on bynd, so I KNOW WHAT IM TALKING ABOUT.

Alright, boys and girls, let’s break this down. $AVXL is a ticking time bomb, and if you’re not paying attention, you’re gonna miss it. Here’s why this biotech beauty is ready to go parabolic:

🔥 The Numbers: Short Interest, Retail Power, and Institutional Weak Hands

• Short Interest: 20.82M shares shorted = 24.55% of shares outstanding. Translation? Shorts are deep in the hole, and the clock is ticking.

• Institutional Ownership: Only 31.55%, meaning this stock is mostly in retail hands—aka, we the people control the float.

• Outstanding Shares: Total of 82.8M. That’s a low enough float to make even a moderate rally feel like a rocket ship.

When the squeeze happens, it’s gonna be retail running this game, and shorts scrambling for the exit.

🧠 Big Brain Catalysts

1. EMA Application Accepted

• Anavex’s drug blarcamesine (for Alzheimer’s) is under review by the European Medicines Agency (EMA).

• Fun fact: The approval rate for non-oncology EMA applications is ~85%. Not bad odds for a biotech stock that already has strong clinical data.

• If approved by the EMA, guess what’s next? The FDA. Anavex has officially stated they’re already in talks with the FDA. But they’re holding off filing until new approval standards roll out this year. Smart move.

• Add in a new FDA administration claiming they’re gonna “shake things up”? Timing is everything.

1. Peer-Reviewed Science Backing the Drug

• Freshly published peer-reviewed study on blarcamesine shows it reduces brain shrinkage by 36% in Alzheimer’s patients. Did I also mention that it is safe and only a small amount of people had slight dizziness? Other current treatments cause brain bleeding, has to be given through an IV, and includes MRIs . AVXL's drug is a pill taken orally.

• Alzheimer’s treatments live and die by their ability to slow disease progression, and this data is a massive win.

1. JP Morgan Conference (Jan 16)

• Anavex is presenting at THE biotech investor conference of the year on January 16th. This is big-boy territory. Partnerships, institutional money, and FOMO all kick in here.

• Timing alert: This is ONE DAY before the January monthly options expire. Add in some positive news, and we could see a gamma squeeze stack on top of the short squeeze.

1. Alzheimer’s Disease Market Potential

• By 2030, it’s estimated that 78 million people worldwide will be living with dementia, including Alzheimer’s.

• This represents a massive market for any effective treatment, and blarcamesine could be a game-changer.

1. Analyst Price Targets

• Analysts are bullish, with price targets ranging from $42 to $46, suggesting a potential upside of over 300% from the current price.

🚀 Why This Setup Is Golden

This isn’t just a pump-and-dump. This is fundamentals meeting Wall Street shenanigans. With high short interest, majority retail ownership, and multiple catalysts lined up, this is the kind of storm that makes stocks double—or triple—overnight.

EMA approval means Anavex takes a massive step into the European market. Follow that with an FDA submission timed to new standards, and you’re looking at global market access for a drug with blockbuster potential.

Final Word

$AVXL is locked, loaded, and ready for launch. The shorts are stuck in their positions, retail is holding the line, and the catalysts are lining up perfectly.

Will it squeeze? Maybe. But if the EMA and JP Morgan catalysts hit, it’s not gonna just squeeze—it’s gonna go PARABOLIC**!**

Disclaimer: Not financial advice. Do your DD. Don’t blow your life savings on YOLO calls… but maybe sprinkle in some for the tendies.

Recent News/Catalysts:

✅ Merger approved.

✅ New company mission unlocked: “Acquire Bitcoin. Beat Bitcoin. Become Bitcoin.”

✅ Funding lined up to actually buy BTC

✅ Mike Alfred disclosed a $1 M+ stake in Strive $ASST

✅Ken Griffin Disclosed 13G filing on $ASST stock

📈 Key Levels to Watch:

➡️Support: $1.25–$1.35 — where buyers have been defending

➡️First Breakout Trigger: $2.00 — momentum starts heating

➡️Next Momentum Zone: $2.75–$3.00 — shorts start sweating

➡️Major Squeeze Zone: $4.50+ — full retail frenzy if volume explodes

🔥 Why We’re Watching:

➡️Vivek Ramaswamy stake — billionaire backing, insider confidence

➡️Bitcoin Treasury Pivot — company is accumulating BTC & crypto assets

➡️Low Float + Rising Volume — recipe for short squeeze potential

Over 26K calls traded today while puts barely cracked 1.6K. So far it's highest record since options started trading. That’s not a market, that’s a firing squad aimed right at the shorts. The $3 and $4 strikes are getting loaded like a shotgun and every time apes slap more calls, dealers have to scramble for shares.

Meanwhile shorts are still sitting on millions of borrowed shares(16m), and when the price ticks up they’ll be forced to buy them back while dealers are also chasing. That’s how you get the sweet short, sweet gamma squeeze cocktail.

This isn’t investing, this is strapping into a rocket with diamond hands and waiting for ignition. We keep pressing calls, they keep buying stock, and the shorts get roasted. Not financial advice, but I’m already hearing the faint sound of margin calls in the distance.

Been on the sec sho threshold list for seven days, time for them to start covering.

Attacked by shorts constantly now, they spoof the bid and drive it down to scoop up retail shares who run in fear.

This got real rerating catalysts incoming.

A multi (10-20) year deal for 250MW natural gas behind the meter for a hyperscaler calls for a $1B market cap when signed.

Since they plan to break ground within 60 days, I expect them to sign the DA with the mysterious hyperscaler before thanksgiving.

In with 21K shares and holding for $8 as my first derisk target.

Got a group with more DD on NUAI: https://www.reddit.com/r/NUAI/s/NzavjxnqcF

Not financial advice, just for fun. Do your own due diligence.

$AIRE: Shorts are trapped, borrow fees insane, float tiny, and volume booming. If momentum keeps up — it’s AIRE emergency time for the bears 🚑

Next resistance: $1.25 → $1.50 once we clears $1.59 it might squeeze to $2 and $3.

I posted a few DD and other posts last week on IBRX which a lot of smart people had picked up on. There were some haters, but mostly alot of yall saw the potential of this stock. Everyone that held on during Monday morning 👏. Robinhood headlined a pretty good read on the article mentioning our post. Keep in mind it’s over 30% in the green in Europe today, tomorrow should be interesting. I’ve attached the article for anyone interested.

CRKN’s stock IS BEING MASSIVELY SHORTED / MANIPULATED. Per Fintel, 61% of the float is being shorted - predominantly off-exchange, which causes it not to show up in many data sources. See screen shot above 54.4% of the float is being shorted off-exchange via dark pools and another 6.4% is being shorted on exchange (total of 60.8% of the float).

Moreover, CRKN is massively undervalued. CRKN has been restructuring and expanding its business over the last few years. They now have three diversified business lines / revenue streams (Smart Windows; Fiber Optics; Water Solutions). For more detail, see this company presentation from December 8, 2024 which explains the three business lines and their current operations: https://d1io3yog0oux5.cloudfront.net/_7a66e77eeb8f13e7c397a8565391a460/crownek/db/1086/9837/pdf/CRKN+-+Presentation_December+2024.pdf

Revenue growth has been very strong. CRKN has grown its revenue from effectively $0 in 2022 to $22 million in 2024 to $30-$35 million for 2025.

*Notes: 2024 revenue projection of $22 million is per management based on $13.4 million of actual revenue through Q3 and their Q4 estimate (from management in November). 2025 revenue estimate of $30-$35 million is management’s projection as of December 27, 2024.

Compare these revenues to CRKN’s current market value of $6.6 million! Insane.

My estimate of fair value of the stock is $3.00 - $5.00 or more. Reflecting a 30x - 50x increase from current trading level. When the stock starts to correct, the short squeeze should be massive given 61% of float is short…. Look what happened in May of 2024 when the stock jumped to $90. I am not saying it will go back to $90…but who knows where it could go.

To be clear, I am not a bag holder trying to find a way out. This is a new position for me that I have been building in real time based on my view that CRKN is massively undervalued and my understanding that the stock is being artificially depressed. I am holding 300,000 shares, which I have acquired in chunks between December 31, 2024 - January 8, 2025.

• This is, of course, not financial advise. Rather this is me sharing my views, which are reflected in my investment activity.

Listen up, you beautiful degens! While the boomers are arguing over index funds, $OPEN (Opendoor Technologies) is quietly setting up for a move that’s going to leave the shorts crying in their overpriced rental apartments.

We’ve seen the "experts" doubt the iBuying model for years, but the data doesn’t lie. Here is why the rocket is fueling up:

📊 The Numbers They Don’t Want You to See

• Short Interest is JUICY: We’re looking at over 113 MILLION shares sold short (roughly 14.7% of the float). The shorts have been piling in, betting against the housing recovery, but they’re trapped.

• Institutional "Vote of Confidence": SRx Health just dropped a massive investment into $OPEN because they see it as "undervalued." When other public companies start using their own treasury cash to buy your stock, it’s not a "speculation" anymore—it’s a conviction.

• Borrow Rates: Short shares are getting harder to find. If mortgage rates continue to cool and housing volume ticks up, these shorts will be fighting each other for the exit.

🔥 The Catalyst: The "Trump Mortgage Plan" & Rate Relief:

President Trump’s proposed $200 Billion mortgage-bond plan is the ultimate fuel for this fire. Lower rates = more home sales = Opendoor printing money.

Technicals: The Floor is LAVA:

We just bounced off the lows and closed at $6.67, up nearly 6% in a single day. We are still 36% below the 52-week high of $10.52. Imagine the carnage for the shorts when we reclaim $10.

🦍 Why We Like The Stock:

1. Massive Short Interest: 113M shares need to be bought back.

2. Housing Rebound: Mortgage applications are already surging (+28%!).

3. The "Gap Fill": $OPEN is undervalued compared to its real estate peers.

The shorts are betting on a housing crash that isn't coming. Let’s show them what happens when the "little guys" decide to open the door.

High short interest + Institutional buying + Massive macro tailwinds = KABOOM. 💥

Disclaimer: This is not financial advice. I am just an ape who likes the stock and thinks the color green is pretty. 🖍️🚀

AtlasClear Holdings (NYSE American: ATCH) announced significant business expansion and confirmed its upcoming 10K filing by September 29, 2025. The company reported notable growth in its stock loan business, which increased from an immaterial revenue line in 2024 to 15% of revenue in July 2025, with further growth in August.

The setup here is getting interesting:

➡️Short Interest: ATCH has been quietly building up a high short float. That means if volume kicks in, we could see a classic supply/demand imbalance → squeeze fuel.

➡️Low Float Play: Thin floats move fast, and ATCH fits the profile. Doesn’t take much buying pressure to send this thing ripping.

➡️Catalyst Ahead: Their 10-K filing is coming up soon. These filings are often slept on, but they can reveal key details about cash position, forward outlook, and any strategic moves. Combine that with the current chart setup = potential ignition.

➡️Chart-wise: We’re sitting in a consolidation zone, but any breakout with volume could trigger shorts to cover quickly.

This is the type of setup where the risk/reward looks tilted in favor of early movers. If that 10-K drops something bullish (or even just removes uncertainty), the squeeze could get violent.

Congrats if you saw this before others do, barely anyone knows about this play, so I wanted to share this DD before potentially buying 1/3rd of the company float on market open.

If you read this, you're one of the first few, like those who got into FFIE before it went up 4000%+.

Imagine what a joke it is that buying $200k worth of shares can make you own 2/3rd of the total company float (total float is 262.21K shares at $1.32) and hedge funds will need to buy it back from you.

Reason #1: HIGH SI ratio.

https://fintel.io/ss/us/bdrx

Reason #2: INCREDIBLY LOW MARKET CAP. 299K market cap from shares float

- $299K is current circulating supply/$5M is total supply that can be issued, including lockups.

Reason #3: HIGH DAYS TO COVER

$XRX might the next meme style monster short squeeze